{{Rsnum
|rsid=218498
|Gene=ATP2C1
|Chromosome=3
|position=130968073
|Orientation=minus
|GMAF=0.3861
|Gene_s=ATP2C1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 42.5 | 43.4 | 14.2
| HCB | 7.3 | 34.3 | 58.4
| JPT | 13.3 | 47.8 | 38.9
| YRI | 0.7 | 12.9 | 86.4
| ASW | 3.5 | 28.1 | 68.4
| CHB | 7.3 | 34.3 | 58.4
| CHD | 1.8 | 42.2 | 56.0
| GIH | 32.7 | 45.5 | 21.8
| LWK | 0.9 | 14.5 | 84.5
| MEX | 19.3 | 45.6 | 35.1
| MKK | 0.6 | 24.4 | 75.0
| TSI | 37.3 | 52.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | Affy GenomeWide 6}}